Literature DB >> 1338267

Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester.

J G Alford1, P L Stanley, G Todderud, K M Tramposch.   

Abstract

We have previously shown that multiple topical applications, over 11 days, of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induces a persistent inflammatory reaction characterized by edema, cell infiltration and epidermal hyperplasia. In order to characterize the cell infiltrate during the establishment of this inflammatory reaction, immunohistochemistry was performed using two monoclonal antibodies: MOMA-2, a macrophage antibody and Thy-1, a pan T-cell antibody. The level of polymorphonuclear leukocytes (PMNs) peaked by day 3 at 160-fold over nontreated controls and then subsided to a 30-fold elevation on days 7-10. By day 4, the number of macrophages increased 2.9-fold over the nontreated control and by day 10 were elevated 6.0-fold over the nontreated control. In comparison, the number of T-cells present by day 7 was significantly elevated 9.5-fold over the nontreated group and peaked at day 8 with a 19-fold elevation relative to nontreated controls. Topical treatment of animals with hydrocortisone valerate resulted in a dramatic (> 60%) reduction in the number of T-cells present in the tissue. In contrast, there was no effect of the steroid on the number of macrophages present in the tissue. The identification of specific cell types and their time course of infiltration is consistent with the development of a chronic inflammatory lesion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338267     DOI: 10.1007/bf02028118

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094).

Authors:  K M Tramposch; F C Zusi; S A Marathe; P L Stanley; X Nair; S A Steiner; J W Quigley
Journal:  Agents Actions       Date:  1990-06

2.  A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis.

Authors:  A Lassus; S Forsstrom
Journal:  Br J Dermatol       Date:  1985-07       Impact factor: 9.302

3.  Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study.

Authors:  G Kraal; M Rep; M Janse
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

4.  Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents.

Authors:  L M De Young; J B Kheifets; S J Ballaron; J M Young
Journal:  Agents Actions       Date:  1989-03

5.  Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate.

Authors:  P L Stanley; S Steiner; M Havens; K M Tramposch
Journal:  Skin Pharmacol       Date:  1991

6.  Effect of glucocorticosteroids on epidermal cell-induced immune responses.

Authors:  W Aberer; L Stingl; S Pogantsch; G Stingl
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment.

Authors:  C M Aldaz; C J Conti; I B Gimenez; T J Slaga; A J Klein-Szanto
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

8.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

Authors:  P P Bradley; D A Priebat; R D Christensen; G Rothstein
Journal:  J Invest Dermatol       Date:  1982-03       Impact factor: 8.551

9.  Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Authors:  R P Carlson; L O'Neill-Davis; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-12

10.  Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells.

Authors:  T Aoki; U Hämmerling; E De Harven; E A Boyse; L J Old
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

View more
  8 in total

1.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

2.  Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation.

Authors:  Ulrich auf dem Keller; Anna Prudova; Ulrich Eckhard; Barbara Fingleton; Christopher M Overall
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

3.  In vitro induced CD8+ regulatory T cells inhibit skin inflammation.

Authors:  D Fleissner; K Loser; W Hansen; J Dissemond; A Körber; S Beissert; J Buer; A M Westendorf
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-09-09

4.  Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

Authors:  Immanuel Lerner; Eyal Zcharia; Tzahi Neuman; Esther Hermano; Ariel M Rubinstein; Israel Vlodavsky; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2013-10-30       Impact factor: 9.261

5.  Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3.

Authors:  Judith A Mack; Ron J Feldman; Naoki Itano; Koji Kimata; Mark Lauer; Vincent C Hascall; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

6.  A peptide derived from phage-display limits psoriasis-like lesions in mice.

Authors:  L A Zapi-Colín; G Gutiérrez-González; S Rodríguez-Martínez; J C Cancino-Diaz; A Méndez-Tenorio; S M Pérez-Tapia; F Gómez-Chávez; C Cedillo-Peláez; M E Cancino-Diaz
Journal:  Heliyon       Date:  2020-06-17

7.  T-cell activation promotes tumorigenesis in inflammation-associated cancer.

Authors:  Dan Rauch; Shimon Gross; John Harding; Sirosh Bokhari; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

8.  Topical Anti-Inflammatory Activity of Oil from Tropidurus hispidus (Spix, 1825).

Authors:  Israel J M Santos; Gerlânia O Leite; José Galberto M Costa; Romulo R N Alves; Adriana R Campos; Irwin R A Menezes; Francisco Ronaldo V Freita; Maria Janeth H Nunes; Waltécio O Almeida
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-18       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.